Nitric oxide and penile erectile function

被引:193
作者
Toda, N
Ayajiki, K
Okamura, T
机构
[1] Toyama Inst Cardiovasc Pharmacol Res, Chuo Ku, Osaka 5410052, Japan
[2] Shiga Univ Med Sci, Dept Pharmacol, Otsu, Shiga 52021, Japan
关键词
nitrergic nerve; penile erection; NO/cyclic GMP; erectile dysfunction; endothelial NOS;
D O I
10.1016/j.pharmthera.2004.11.011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The discovery of nitric oxide (NO) as an intercellular messenger or neurotransmitter opened a new era for identifying the important mechanisms underlying physiological and pathophysiological events in autonomically innervated organs and tissues; it also provided the way for development of new therapeutics based on a novel concept of molecule and cell interaction. Endothelium-derived relaxing factor (EDRF) discovered by Furchgott and Zawadzki has been proved to be NO, a labile gaseous molecule, that modulates vascular tone, platelet aggregation and adhesion, and vascular smooth muscle proliferation. Later, NO was determined to act as a non-adrenergic, non-cholinergic (NANC) neurotransmitter of postganglionic parasympathetic nerve fibers, innervating a variety of smooth muscles including the penile corpus cavernosum (CC). The nerve is called "nitrergic" or "nitroxidergic". Although CC sinusoidal endothelial cells also produce and liberate NO in response to chemical and possibly physical stimuli, roles of neurogenic NO in penile erection appear to be more attractive and convincing. NO is formed from L-arginine via catalysis by NO synthase (NOS) isoforms, neuronal (nNOS), endothelial (eNOS), and inducible NOS. NO from nerves and possibly endothelia plays a crucial role in initiating and maintaining intracavernous pressure increase, penile vasodilatation, and penile erection that are dependent on cyclic GMP synthesized with activation of soluble guanyly cyclase by NO in smooth muscle cells. Erectile dysfunction (ED) is caused by a variety of pathogenic factors, particularly impaired formation and action of NO. Thus, replenishment of this molecule or intracellular cyclic GMP is expected so far to be the most promising therapeutic measures for patients with ED. This article includes recent advances in research on physiological roles and pathophysiological implications of NO in penile erection and on novel therapy for ED in reference to NO. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:233 / 266
页数:34
相关论文
共 432 条
[71]   RADIATION-INDUCED DECREASE IN NITRIC-OXIDE SYNTHASE-CONTAINING NERVES IN THE RAT PENIS [J].
CARRIER, S ;
HRICAK, H ;
LEE, SS ;
BABA, K ;
MORGAN, DM ;
NUNES, L ;
ROSS, GY ;
PHILLIPS, TL ;
LUE, TF .
RADIOLOGY, 1995, 195 (01) :95-99
[72]   Age decreases nitric oxide synthase-containing nerve fibers in the rat penis [J].
Carrier, S ;
Nagaraju, P ;
Morgan, DM ;
Baba, K ;
Nunes, L ;
Lue, TF .
JOURNAL OF UROLOGY, 1997, 157 (03) :1088-1092
[73]   Effect of the selective phosphodiesterase type 5 inhibitor sildenafil on erectile function in the anesthetized dog [J].
Carter, AJ ;
Ballard, SA ;
Naylor, AM .
JOURNAL OF UROLOGY, 1998, 160 (01) :242-246
[74]  
Cartledge J, 2001, Expert Opin Pharmacother, V2, P95, DOI 10.1517/14656566.2.1.95
[75]   Advanced glycation end-products are responsible for the impairment of corpus cavernosal smooth muscle relaxation seen in diabetes [J].
Cartledge, JJ ;
Eardley, I ;
Morrison, JFB .
BJU INTERNATIONAL, 2001, 87 (04) :402-407
[76]   Effects of sildenafil on erectile activity in mice lacking neuronal or endothelial nitric oxide synthase [J].
Cashen, DE ;
MacIntyre, DE ;
Martin, WJ .
BRITISH JOURNAL OF PHARMACOLOGY, 2002, 136 (05) :693-700
[77]   Nitrergic control of peripheral sympathetic responses in the human corpus cavernosum: A comparison with other species [J].
Cellek, S ;
Moncada, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (15) :8226-8231
[78]   A Rho-kinase inhibitor, soluble guanylate cyclase activator and nitric oxide-releasing PDE5 inhibitor: novel approaches to erectile dysfunction [J].
Cellek, S ;
Rees, RW ;
Kalsi, J .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2002, 11 (11) :1563-1573
[79]   Nitrergic-noradrenergic interaction in penile erection: A new insight into erectile dysfunction [J].
Cellek, S .
DRUGS OF TODAY, 2000, 36 (2-3) :135-146
[80]   Selective nitrergic neurodegeneration in diabetes mellitus -: a nitric oxide-dependent phenomenon [J].
Cellek, S ;
Rodrigo, J ;
Lobos, E ;
Fernández, P ;
Serrano, J ;
Moncada, S .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 128 (08) :1804-1812